Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 7 / Drugs : 11 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 35

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Buspirone
   Massachusetts General Hospital
      2021   Phase 4   NCT04807517   United States
Clemastine fumarate tablets
   Qilu Hospital of Shandong University
      2024   Phase 3   NCT06315699   China
Cozaar 50 MG comprimidos recubierto CON pelicula
   Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
      2009   -   EUCTR2007-006059-37-ES   Spain
Fructose
   Qilu Hospital of Shandong University
      2024   Phase 3   NCT06315699   China
Lonoten
   Hospices Civils de Lyon
      2008   Phase 2   EUCTR2006-005745-11-FR   France
Losartan potasico
   Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
      2009   -   EUCTR2007-006059-37-ES   Spain
Losartan potassium
   Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
      2009   -   EUCTR2007-006059-37-ES   Spain
Methylphenidate, fluoxetin, risperidone
   The Chaim Sheba Medical Center
      2001   Phase 4   NCT00768820   Israel
Minoxidil
   Hospices Civils de Lyon
      2008   Phase 2   EUCTR2006-005745-11-FR   France
Open label clemastine with A blinded randomize withdrawal
   Sheba Medical Center
      2024   Phase 3   NCT06087757   Israel
Vitamin D
   National Center for Research Resources (NCRR)
      1998   -   NCT00013962   United States